Encorafenib
Enasidenib Mesylate is an anticancer drug (IDH2 inhibitor).
| Catalog Number | API0232811 |
| Alternative Name(s) | Encorafenib; 1269440-17-6; LGX818 |
| Research Area | API |
| Molecular Formula | C22H27ClFN7O4S |
| CAS# | 1269440-17-6 |
| Inchi | InChI=1S/C22H27ClFN7O4S/c1-12(2)31-11-16(17-6-7-25-21(28-17)26-10-13(3)27-22(32)35-4)20(29-31)15-8-14(23)9-18(19(15)24)30-36(5,33)34/h6-9,11-13,30H,10H2,1-5H3,(H,27,32)(H,25,26,28)/t13-/m0/s1 |
| Inchi Key | CMJCXYNUCSMDBY-ZDUSSCGKSA-N |
| SMILES | C[C@@H](CNC1=NC=CC(=N1)C2=CN(N=C2C3=C(C(=CC(=C3)Cl)NS(=O)(=O)C)F)C(C)C)NC(=O)OC |
| Size | inquiry |
| Supplier Page | https://apihub.protheragen.ai/encorafenib-item-1311.html |